Hodgkin Lymphoma Flashcards

1
Q

What is the classic pathology finding in Hodgkin Lymphoma?

A

Reed-Sternberg cells surrounded by inflammation
RS cells recruit inflammatory cells, and then only make up 10% or less of the whole tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two viral infections are risk factors for Hodgkin lymphoma?

A

EBV
HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Immunophenotype of Nodular lymphocyte predominant Hodgkin?

A

CD19+, CD20+, CD45+, Cd79a+, PAX5+, OCT2+
Cd15-, CD30-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immunophenotype of classic Hodgkin Lymphoma

A

Cd15+, CD30+, PAX5 dim
Negative for CD19, CD20, BOB1, OCT2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosis:
CD15+, CD30+, PAX5 dim
CD19-, Cd20-, CD45-

A

Classic HL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diagnosis: CD19+, CD20+, CD45+, CD79a+, PAX5+
d15-, Cd30-

A

Nodular LP HL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In staging HL, what do the A and B designations mean?

A

A = no constitutional symptoms
B = fevers, NS, weight loss, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do you calssify someone with bulky mediastinal disease?

A

Mediastinal mass:thoracic ratio >0.33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What classifies someone with UNFAVORABLE early stage HL? (5)

A

Any of the following:
1. age >50
2. mediastinal mass:thoracic ratio >0.33
3. ESR >3 with B symptoms or ESR >50
4. Any extranodal involvement
5. >3 involved LN areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is stage I HL?

A

One single site of lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is stage II HL?

A

Multiple sites on one side of diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is stage III HL?

A

Nodal involvement above and below diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is stage IV HL?

A

Extranodal involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What stages are considered early stage?

A

I-II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What Deauville scores typically denote a remission?

A

1-2
(sometimes 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

FDG uptake is more than mediastinum but equal or less than liver. Deauville?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

FDG uptake is less than mediastinum. Deauville?

18
Q

FDG is moderately increased compared to the liver, but is improved from baseline, no new sites of disease. Deauville?

19
Q

What drugs are in ABVD?

A

Doxorubicin
Bleomycin
Vinblastine
Dacarbazine

20
Q

Treatment options for early stage, favorable HL

A

PET Adapted ABVD after 2C
If PET negative, then ISRT 20 Gy or ABVD x1C + ISRT 30 Gy
If PET DS3, then AVD 4C or ABVDx2+ 30Gy ISRT
If PET DS4, then 2C ABVD and anothher PET.

21
Q

Treatment for nonbulky unfavorable early stage HL?

A

PET-Adapted ABVD (if non-bulky)

22
Q

Patient with newly diagnosed advanced stage HL is treated with ABVD. PET after C2 shows Deauville 2. What to do?

A

Omit bleomycin and do AVD for 4 more cycles

23
Q

What treatment regimen provides the best disease control in advanced stage HL?

A

Escalated BEACOPP
(Bleo, Etop, Doxo, Cyclophos, Vincristine, Procarbazine, Pred)

24
Q

Significant toxicities with BEACOPP (2)

A

Infertility
MDS/AML

25
For those with advanced stage HL, which patients would benefit most from Brentuximab vedotin + AVD? (3)
Younger patients (<60) Multiple extranodal sites Stage IV
26
Treatment options for advanced stage HL? (2)
N-AVD (Nivolumab, Doxo, Vinblast, Dacarbazine) BrECADD (Bv, Etop, Cyclophos, Doxo, Dacarbazine, Dex) PET-Adapted ABVD Bv-AVD (not as good as N-AVD but that's a new regimen)
27
N-AVD was compared to Bv-AVD. What what the PFS comparison?
N-AVD was better across subgroups
28
What was the treatment outcome difference between BrECADD and escBEACOPP
BrECADD improved PFS and was less toxic
29
What is the general treatment paradigm for R/R HL?
Salvage chemotherapy followed by autoHCT
30
What are examples of salvage chemotherapy regimens used in R/R HL? (4)
ICE, DHAP, GVP, GDP
31
What is prognostic after salvage chemotherapy for good outcomes?
PET negative CR prior to autoHCT
32
Treatment options for R/R HL after autoHCT? (3)
Brentuximab vedotin Nivo Pembro (should be done before BV)
33
Who is eligible for BV consolidation therapy after AutoHCT? (4)
Relapse within 1 year of frontline therapy Extranodal disease at relapse PET+ at time of transplant >1 salvage therapy
34
How to sequence BV and Pembro in R/R HL?
Pembro first
35
Treatment of Stage I Nodular LP HL?
RT alone
36
Early stage treatment of Nodular LP HL?
R-CVP
37
Treatment of advanced Nodular LP HL?
R-CHOP R-CVP
38
In patients with HL who received RT, how do you manage secondary cancer risk?
Mammograms yearly after mediastinal/axillary RT (or MRI in pts <30) Start 8-10 years after treatment or at 40 years old
39
Treatment for bulky favorable early stage HL? (3)
ABVD x4 + 30 Gy IF RT BEACOPP x2 + ABVD x2 + 30 Gy ISRT ABVD x6
40
Describe the PET-Adapted approach to ABVD in unfavorable early HL?
2 cycles of ABVD - then PET. If PET is DS 1-3, then AVD x4C is given, or ABVDx2 + ISRT 30 Gy. If PET is DS 4-5, then escBEACOPPx2. Then another PET. If that's DS1-3, then BEACOPPx2 or ISRT 30 Gy
41
What type of HL is treated distinctly from classic HL and other variants? How is it treated differently?
Nodular lymphocyte predominant HL It's CD19 and CD20+, so Rituximab based regimens are useful
42
Describe the PET-adapted approach to favorable, early stage HL?
After 2C ABVD: DS 1-2: ISRT 20 Gy OR ABVD x1 + ISRT 30 Gy OR ABVD x2C DS 3+: BEACOPP +/- ISRT